Chief Technology & AI Officer
ICBD · Healthcare Technology / Private Equity Portfolio · 50-200 employees · 📍 Fort Lauderdale, FL
Founding CTO/CAIO for a PE-style healthcare single-family office portfolio, tasked with building and commercializing bespoke AI products across portfolio companies—including a dedicated AI platform (Curative AI)—while acting as the revenue-generating technical bridge to clients.
Key Responsibilities
- Define and execute enterprise-wide technology and AI strategy aligned to ICBD portfolio growth
- Lead AI innovation and commercialization of bespoke AI products across portfolio companies
- Serve as primary technical liaison between client-facing/sales teams and engineering
- Drive operational excellence by automating processes and building scalable, secure systems
- Translate technical concepts into business language for senior leadership, clients, and partners
Requirements
- 10+ years in technology leadership, ideally in healthcare sector
- 5+ years AI/ML strategy experience with hands-on bespoke AI solution development
- Proven track record commercializing technical innovations and driving product revenue
- Experience managing AI/ML teams
- M&A transaction exposure, preferably in PE or similar environment
- MBA or Master's degree
Signals
- ⚠ No salary posted — may indicate compensation is still being structured or is non-competitive
- ⚠ Role posted at least twice (May 30, 2026 and current) suggesting difficulty filling
- ⚠ Very broad scope — technology leadership, AI innovation, commercial growth, and M&A all in one role
- ⚠ Company brand (ICBD) has low public profile, limiting external validation of legitimacy and scale
- ✓ Founding CTO/CAIO mandate — rare greenfield opportunity with full ownership
- ✓ Direct reporting line to CEO with EY Entrepreneur of the Year pedigree
- ✓ Dedicated AI platform subsidiary (Curative AI) already established
- ✓ PE/family office backing implies access to capital and multiple portfolio companies as clients
- ✓ Healthcare AI commercialization is a high-growth, high-value sector
Company History
Posted at least twice on the same date (May 30, 2026) with slightly different framings — one emphasizing the single-family office/Curative AI angle, one emphasizing PE-backed portfolio commercialization — suggesting the role may be actively being shopped across multiple channels simultaneously rather than indicating a failed prior hire. This is a genuinely new founding role, not a backfill.